Showing results (4911-4920 of 9,342) with videos related to

Sort By:
Pageof 935
Cancer Medicine|December 11, 2019
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcomaVictor M Villalobos, Gary Mo, Mark Agulnik, et al.
Cancer Medicine|December 11, 2019
Autoimmune diseases and immunosuppressive therapy in relation to the risk of gliomaTareq M Anssar, Michael F Leitzmann, Ralf A Linker, et al.
Cancer Medicine|October 30, 2019
Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsyJing Si, Rong Guo, Naisi Huang, et al.
Cancer Medicine|October 31, 2019
Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER databaseKaiwen Shen, Longdi Yao, Jinli Wei, et al.
Cancer Medicine|October 31, 2019
Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control studyXing-Zhizi Wang, Wei-Zhong Tang, Qun-Ying Su, et al.
Cancer Medicine|December 9, 2022
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation studyToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Cancer Medicine|November 22, 2022
On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happeningsBlessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, et al.
Cancer Medicine|September 22, 2020
Trimodal therapy in T2-4aN0M0 bladder cancer--How to select the best candidate?Ofer N Gofrit, Amichay Meirovitz, Stephen Frank, et al.
Cancer Medicine|September 24, 2020
Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinomaShitong Lin, Lingling Zheng, Yuchao Lu, et al.
Cancer Medicine|April 2, 2020
Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsinZahra Najafi, Abdolreza Mohamadnia, Rahim Ahmadi, et al.
Pageof 935